Why the study?
Are circulating biomarkers of fibrosis (TGF-β and PIIINP) associated with incident cardiovascular disease in community-living older adults?
Are circulating biomarkers of fibrosis (TGF-β and PIIINP) associated with incident cardiovascular disease in community-living older adults?
Circulating biomarkers of fibrosis, particularly PIIINP, are associated with incident cardiovascular disease and heart failure in older adults, with TGF-β showing risk primarily in the setting of elevated inflammation.
Answers are grounded in this paper and cite their sources.
May support risk stratification in older adults; hypothesis-generating and requires prospective validation before clinical adoption.
BACKGROUND: Fibrotic changes in the heart and arteries have been implicated in a diverse range of cardiovascular diseases (CVD), but whether circulating biomarkers that reflect fibrosis are associated with CVD is unknown. METHODS AND RESULTS: We determined the associations of 2 biomarkers of fibrosis, transforming growth factor- β (TGF-β), and procollagen type III N-terminal propeptide (PIIINP), with incident heart failure, myocardial infarction, and stroke among community-living older adults in the Cardiovascular Health Study. We measured circulating TGF-β (n=1371) and PIIINP (n=2568) from plasma samples collected in 1996 and ascertained events through 2010. Given TGF-β's pleiotropic effects on inflammation and fibrogenesis, we investigated potential effect modification by C-reactive protein in secondary analyses. After adjustment for sociodemographic, clinical, and biochemical risk factors, PIIINP was associated with total CVD (hazard ratio [HR] per SD=1.07; 95% confidence interval [CI], 1.01-1.14) and heart failure (HR per SD=1.08; CI, 1.01-1.16) but not myocardial infarction or stroke. TGF-β was not associated with any CVD outcomes in the full cohort but was associated with total CVD (HR per SD=1.16; CI, 1.02-1.31), heart failure (HR per SD=1.16; CI, 1.01-1.34), and stroke (HR per SD=1.20; CI, 1.01-1.42) among individuals with C-reactive protein above the median, 2.3 mg/L (P interaction <0.05). CONCLUSIONS: Our findings provide large-scale, prospective evidence that circulating biomarkers of fibrosis, measured in community-living individuals late in life, are associated with CVD. Further research on whether TGF-β has a stronger fibrogenic effect in the setting of inflammation is warranted.
No takes yet. Share an insight, caveat, or question.
Agarwal et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: